Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Reticular Dermis01:15

Reticular Dermis

The papillary and reticular dermis are the two layers of the dermis. They are made of connective tissue with fibers of collagen extending from one to the other, making the border between the two somewhat indistinct. The dermal papillae extending into the epidermis belong to the papillary layer, whereas the dense collagen fiber bundles below belong to the reticular layer.
Reticular Layer
Underlying the papillary layer is the much thicker reticular layer, composed of dense, irregular connective...
Healing II: Complications01:24

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models.

Scientific reports·2026
Same author

Hidden Targets in Cancer Immunotherapy: The Potential of "Dark Matter" Neoantigens.

Vaccines·2026
Same author

Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients.

Oxford open immunology·2026
Same author

Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy.

Cell reports. Medicine·2024
Same author

Mesothelioma survival prediction based on a six-gene transcriptomic signature.

iScience·2024
Same author

Trends in smoking initiation and cessation over a century in two Australian cohorts.

PloS one·2024

Related Experiment Video

Updated: Jul 16, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Malignant mesothelioma.

Bruce W S Robinson1, Arthur W Musk, Richard A Lake

  • 1Tumour Immunology Group, School of Medicine and Pharmacology, University of Western Australia, Australia. bwsrobin@cyllene.uwa.edu.au

Lancet (London, England)
|August 2, 2005
PubMed
Summary

Malignant mesothelioma is an aggressive cancer linked to asbestos and potentially simian virus 40 (SV40). Its molecular pathology involves specific tumor suppressor gene loss, aiding diagnosis and prognostication.

Area of Science:

  • Oncology
  • Pathology
  • Virology

Background:

  • Malignant mesothelioma is an aggressive, increasingly frequent cancer.
  • Asbestos exposure is the primary risk factor, with simian virus 40 (SV40) as a potential contributor.
  • The disease presents with symptoms like breathlessness and chest pain, often with pleural effusions.

Purpose of the Study:

  • To summarize the key aspects of malignant mesothelioma, including its etiology, pathology, diagnosis, and current treatment strategies.
  • To highlight the unique molecular characteristics of mesothelioma.
  • To discuss the potential role of novel diagnostic and prognostic tools.

Main Methods:

  • Review of current literature on malignant mesothelioma.
  • Analysis of cytopathological and histopathological diagnostic criteria.

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Related Experiment Videos

Last Updated: Jul 16, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

  • Examination of molecular pathology, focusing on tumor suppressor gene alterations.
  • Consideration of microarray study findings for diagnosis and prognostication.
  • Main Results:

    • Mesothelioma exhibits distinct molecular pathology, characterized by loss of P16INK4A, P14ARF, and NF2 tumor suppressor genes.
    • Cytopathology and histopathology are crucial for diagnosis.
    • Median survival is approximately 12 months post-diagnosis.
    • Palliative chemotherapy benefits patients with good performance status.

    Conclusions:

    • Malignant mesothelioma requires a multi-faceted diagnostic approach.
    • Understanding its unique molecular profile is key for diagnosis and prognostication.
    • Further research into gene therapy, immunotherapy, and microarray patterns is warranted.